ALAN PENN AND ASSOCIATES, INC.

Medtech · Private

Computer-aided diagnosis (CAD) software system for breast cancer detection using novel Diffusion Weighted Imaging (DWI) analysis methods

Grants
$677K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Diffusion Weighted Breast MR Imaging for Screening Women with Dense Breasts$676,958
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
673LAB TO PHARMACY LLC——
674Desert Valley Tech Inc.——
675APPLIED PARTICLE TECHNOLOGY, LLC——
676ALAN PENN AND ASSOCIATES, INC.——
677INTEGRATED SENSING SYSTEMS, INC. (ISSYS)——
678LumiraDx Ltd—$682M
679ADVANCED VASCULAR THERAPIES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.